Treatment Response Assessment of Head and Neck Cancers on CT Using Computerized Volume Analysis

BACKGROUND AND PURPOSE: Head and neck cancer can cause substantial morbidity and mortality. Our aim was to evaluate the potential usefulness of a computerized system for segmenting lesions in head and neck CT scans and for estimation of volume change of head and neck malignant tumors in response to treatment. MATERIALS AND METHODS: CT scans from a pretreatment examination and a post 1-cycle chemotherapy examination of 34 patients with 34 head and neck primary-site cancers were collected. The computerized system was developed in our laboratory. It performs 3D segmentation on the basis of a level-set model and uses as input an approximate bounding box for the lesion of interest. The 34 tumors included tongue, tonsil, vallecula, supraglottic, epiglottic, and hard palate carcinomas. As a reference standard, 1 radiologist outlined full 3D contours for each of the 34 primary tumors for both the pre- and posttreatment scans and a second radiologist verified the contours. RESULTS: The correlation between the automatic and manual estimates for both the pre- to post-treatment volume change and the percentage volume change for the 34 primary-site tumors was 0.95, with an average error of −2.4 ± 8.5% by automatic segmentation. There was no substantial difference and specific trend in the automatic segmentation accuracy for the different types of primary head and neck tumors, indicating that the computerized segmentation performs relatively robustly for this application. CONCLUSIONS: The tumor size change in response to treatment can be accurately estimated by the computerized segmentation system relative to radiologists' manual estimations for different types of head and neck tumors.

[1]  Douglas G. Altman,et al.  Measurement in Medicine: The Analysis of Method Comparison Studies , 1983 .

[2]  R. D. Hunter,et al.  WHO Handbook for Reporting Results of Cancer Treatment , 1980 .

[3]  W. Mendenhall,et al.  Irradiation alone for supraglottic larynx carcinoma: can CT findings predict treatment results? , 1990, International journal of radiation oncology, biology, physics.

[4]  S. Mukherji,et al.  Preradiotherapy computed tomography as a predictor of local control in supraglottic carcinoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  D. Chua,et al.  Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. , 1997, International journal of radiation oncology, biology, physics.

[6]  W. Hong,et al.  Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. , 1991, The New England journal of medicine.

[7]  W. Mendenhall,et al.  Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy? , 1997, International journal of radiation oncology, biology, physics.

[8]  J. Ensley,et al.  An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  H. Chan,et al.  Head and neck cancers on CT: preliminary study of treatment response assessment based on computerized volume analysis. , 2010, AJR. American journal of roentgenology.

[10]  J. Pignon,et al.  Individual patients' data meta-analyses in head and neck cancer , 2007, Current opinion in oncology.

[11]  L. Collette,et al.  Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. , 1996, Journal of the National Cancer Institute.

[12]  A L Baert,et al.  Value of computed tomography as outcome predictor of supraglottic squamous cell carcinoma treated by definitive radiation therapy. , 1999, International journal of radiation oncology, biology, physics.

[13]  H D Thames,et al.  The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography. , 1995, International journal of radiation oncology, biology, physics.

[14]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[15]  J. Hornaday,et al.  Cancer Facts & Figures 2004 , 2004 .

[16]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[17]  B. Jeremic,et al.  Hyperfractionated Radiation Therapy With or Without Concurrent Low-Dose Daily Cisplatin in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Prospective Randomized Trial , 2000 .

[18]  M. Leblanc,et al.  Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Lubomir M. Hadjiiski,et al.  Automated volume analysis of head and neck lesions on CT scans using 3D level set segmentation. , 2007, Medical physics.

[20]  J. Fleiss,et al.  Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.

[21]  J. Bourhis,et al.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data , 2000, The Lancet.

[22]  Alicia Y Toledano,et al.  Interobserver reliability of computed tomography‐derived primary tumor volume measurement in patients with supraglottic carcinoma , 2005, Cancer.

[23]  J E Husband,et al.  Evaluation of the response to treatment of solid tumours – a consensus statement of the International Cancer Imaging Society , 2004, British Journal of Cancer.

[24]  M. Christian,et al.  [New guidelines to evaluate the response to treatment in solid tumors]. , 2000, Bulletin du cancer.

[25]  R. Weber,et al.  Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. , 2003, The New England journal of medicine.